荃灣海之戀-愛炫美4伙終止交易 大手客料損手近980萬元
據《經濟日報》引述成交紀錄冊資料指,由長實集團(01113.HK)發展的荃灣海之戀-愛炫美(海之戀第3A期)今日(26日)一口氣錄得4伙終止買賣合約,涉及5A座中高至高層四個單位,成交價介乎2,406.2萬至2,504.1萬元,買家採用「輕鬆置業付款B計劃」,料最少已付20%訂金,估計損失481萬至500.8萬元不等。
當中,一名吳氏買家分別以2,487.1萬及2,406.2萬大手買入5A座中高層A及B室,是次放棄上會,料損失逾978萬元。
發展商同日公布銷售安排,於下周一(12月2日)至明年2月24日期間,以招標形式賣上述4伙撻訂戶。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.